Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Cash and Short-Term Investments

Amag Pharmaceuticals Cash and Short-Term Investments Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Cash and Short-Term Investments from 2010 to 2020.
  • Amag Pharmaceuticals Cash and Short-Term Investments for the quarter ending June 06, 2020 was $147m a -30.20% decrease of -44m year over year
  • Amag Pharmaceuticals Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $147m a -30.20% decrease of -44m year over year
  • Amag Pharmaceuticals Annual Cash and Short-Term Investments for 2019 was $172m a -129.50% decrease of -222m from 2018
  • Amag Pharmaceuticals Annual Cash and Short-Term Investments for 2018 was $394m a 24.03% increase of 95m from 2017
  • Amag Pharmaceuticals Annual Cash and Short-Term Investments for 2017 was $299m a -93.38% decrease of -280m from 2016
Other Balance Sheet Metrics:
  • Amag Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $1,216m a -52.43% decrease of -637m year over year
  • Amag Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a -3,223.97% decrease of -46m year over year
  • Amag Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $762m a -3.67% decrease of -28m year over year
View Chart On Koyfin

Quarterly AMAG Cash and Short-Term Investments Data

06/2020$147m
03/2020$125m
12/2019$172m
09/2019$192m
06/2019$261m
03/2019$267m
12/2018$394m
09/2018$428m
06/2018$351m
03/2018$371m

Annual AMAG Cash and Short-Term Investments Data

2019$172m
2018$394m
2017$299m
2016$579m
2015$466m
2014$144m
2013$214m
2012$227m
2011$212m
2010$260m